These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12657363)

  • 1. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does neuronal loss in Parkinson's disease involve programmed cell death?
    Andersen JK
    Bioessays; 2001 Jul; 23(7):640-6. PubMed ID: 11462217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuronal death caused by apoptosis in Parkinson disease].
    Ruberg M; France-Lanord V; Brugg B; Lambeng N; Michel PP; Anglade P; Hunot S; Damier P; Faucheux B; Hirsch E; Agid Y
    Rev Neurol (Paris); 1997 Sep; 153(8-9):499-508. PubMed ID: 9683999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic approach in the study of an animal model of Parkinson's disease.
    De Iuliis A; Grigoletto J; Recchia A; Giusti P; Arslan P
    Clin Chim Acta; 2005 Jul; 357(2):202-9. PubMed ID: 15946658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
    Waldmeier PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of prostate apoptosis response-4 protein in substantia nigra of Parkinson's disease autopsies.
    Moos T; Jensen PH
    Acta Neuropathol; 2004 Jan; 107(1):23-6. PubMed ID: 13680279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease.
    He XJ; Yamauchi H; Uetsuka K; Nakayama H
    Neurotoxicology; 2008 May; 29(3):413-20. PubMed ID: 18387672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death in the substantia nigra: a motor tragedy.
    Esposito E; Di Matteo V; Di Giovanni G
    Expert Rev Neurother; 2007 Jun; 7(6):677-97. PubMed ID: 17563251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?
    Ziv I; Zilkha-Falb R; Offen D; Shirvan A; Barzilai A; Melamed E
    Mov Disord; 1997 Jan; 12(1):17-23. PubMed ID: 8990049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammation and Parkinson's disease].
    Barcia González C; Herrero Ezquerro MT
    Rev Neurol; 2004 Mar 16-31; 38(6):545-53. PubMed ID: 15054720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
    De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
    Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.